Co-Authors
This is a "connection" page, showing publications co-authored by Olivier Schwartz and Ludivine Grzelak.
Connection Strength
1.114
-
Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2. J Infect Dis. 2021 09 17; 224(6):983-988.
Score: 0.242
-
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies. Nat Med. 2021 05; 27(5):917-924.
Score: 0.234
-
A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations. Sci Transl Med. 2020 09 02; 12(559).
Score: 0.224
-
Analysis of T-cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in patients with chilblain-like lesions during the COVID-19 pandemic. Br J Dermatol. 2021 12; 185(6):1242-1244.
Score: 0.060
-
Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection. Sci Adv. 2021 08; 7(34).
Score: 0.060
-
A monocyte/dendritic cell molecular signature of SARS-CoV-2-related multisystem inflammatory syndrome in children with severe myocarditis. Med (N Y). 2021 Sep 10; 2(9):1072-1092.e7.
Score: 0.060
-
Characteristics Associated with Olfactory and Taste Disorders in COVID-19. Neuroepidemiology. 2021; 55(5):381-386.
Score: 0.060
-
Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies. Cell Rep Med. 2021 05 18; 2(5):100275.
Score: 0.059
-
SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020. Euro Surveill. 2021 04; 26(15).
Score: 0.059
-
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France. EBioMedicine. 2020 Sep; 59:102915.
Score: 0.056